Suppr超能文献

人类自身免疫中的 CD4+FOXP3+ T 调节性细胞:不仅仅是数字游戏。

CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game.

机构信息

Benaroya Research Institute at Virginia Mason, Seattle, WA 98101, USA.

出版信息

J Immunol. 2011 Sep 1;187(5):2061-6. doi: 10.4049/jimmunol.1003224.

Abstract

Regulatory T cells (Treg) play a dominant role in suppression of autoimmune pathology, as rescue of Treg number and/or function in model systems can both prevent and reverse disease. These findings have generated a series of studies addressing the role of defects in Treg number and function in human autoimmunity. However, demonstrating global defects in Treg of individuals diagnosed with autoimmune diseases has been challenging. These challenges are founded, in part, in the complexity of human autoimmune diseases in which various genetic factors and environmental triggers contribute to disease susceptibility. Moreover, contribution of failed Treg-mediated suppression to pathogenesis can extend to multiple mechanisms. In this article, we discuss what is known with respect to the number and function of CD4(+)FOXP3(+) Treg in human autoimmunity, focusing on representative autoimmunediseases in which there are diverse Treg-mediated defects. We also highlight the need to better understand Treg plasticity and function in the context of autoimmunity.

摘要

调节性 T 细胞(Treg)在抑制自身免疫病理学中发挥主导作用,因为在模型系统中挽救 Treg 的数量和/或功能既可以预防又可以逆转疾病。这些发现引发了一系列研究,探讨了 Treg 数量和功能缺陷在人类自身免疫中的作用。然而,证明诊断为自身免疫性疾病的个体的 Treg 存在普遍缺陷具有挑战性。这些挑战部分基于人类自身免疫性疾病的复杂性,其中各种遗传因素和环境触发因素导致疾病易感性。此外,Treg 介导的抑制作用失败对发病机制的贡献可以扩展到多种机制。在本文中,我们讨论了在人类自身免疫中 CD4(+)FOXP3(+)Treg 的数量和功能方面的已知情况,重点介绍了存在多种 Treg 介导缺陷的代表性自身免疫性疾病。我们还强调需要更好地理解自身免疫背景下 Treg 的可塑性和功能。

相似文献

1
CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game.
J Immunol. 2011 Sep 1;187(5):2061-6. doi: 10.4049/jimmunol.1003224.
2
The role of FOXP3 regulatory T cells in human autoimmune and inflammatory diseases.
Clin Exp Immunol. 2019 Jul;197(1):24-35. doi: 10.1111/cei.13288. Epub 2019 Mar 24.
3
Few Foxp3⁺ regulatory T cells are sufficient to protect adult mice from lethal autoimmunity.
Eur J Immunol. 2014 Oct;44(10):2990-3002. doi: 10.1002/eji.201344315. Epub 2014 Aug 11.
4
Regulatory T cell metabolism at the intersection between autoimmune diseases and cancer.
Eur J Immunol. 2020 Nov;50(11):1626-1642. doi: 10.1002/eji.201948470. Epub 2020 Oct 26.
5
Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):8490-5. doi: 10.1073/pnas.1608873113. Epub 2016 Jul 7.
6
CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas.
Curr Opin Immunol. 2008 Dec;20(6):655-62. doi: 10.1016/j.coi.2008.09.006. Epub 2008 Oct 28.
7
Human FoxP3+ regulatory T cells in systemic autoimmune diseases.
Autoimmun Rev. 2011 Oct;10(12):744-55. doi: 10.1016/j.autrev.2011.05.004. Epub 2011 May 18.
8
Membrane-bound Dickkopf-1 in Foxp3 regulatory T cells suppresses T-cell-mediated autoimmune colitis.
Immunology. 2017 Oct;152(2):265-275. doi: 10.1111/imm.12766. Epub 2017 Jun 27.
10

引用本文的文献

2
The TET-TDG axis in T cells and biological processes.
Int Immunol. 2025 May 21;37(6):299-312. doi: 10.1093/intimm/dxaf006.
3
Altered characteristics of regulatory T cells in target tissues of Sjögren's syndrome in murine models.
Mol Immunol. 2024 Oct;174:47-56. doi: 10.1016/j.molimm.2024.08.003. Epub 2024 Aug 27.
4
The role of CD4 T cells in visceral leishmaniasis; new and emerging roles for NKG7 and TGFβ.
Front Cell Infect Microbiol. 2024 May 31;14:1414493. doi: 10.3389/fcimb.2024.1414493. eCollection 2024.
5
Risk of Type 1 Diabetes Mellitus in SARS-CoV-2 Patients.
Curr Diabetes Rev. 2025;21(5):e240524230298. doi: 10.2174/0115733998290807240522045553.
6
Tipping the balance in autoimmunity: are regulatory t cells the cause, the cure, or both?
Mol Cell Pediatr. 2024 Mar 20;11(1):3. doi: 10.1186/s40348-024-00176-8.
7
Improving regulatory T cell production through mechanosensing.
J Biomed Mater Res A. 2024 Jul;112(7):1138-1148. doi: 10.1002/jbm.a.37702. Epub 2024 Mar 7.
8
Mitochondrial-regulated Tregs: potential therapeutic targets for autoimmune diseases of the central nervous system.
Front Immunol. 2023 Dec 12;14:1301074. doi: 10.3389/fimmu.2023.1301074. eCollection 2023.
9
Integration of liquid biopsy and immunotherapy: opening a new era in colorectal cancer treatment.
Front Immunol. 2023 Nov 21;14:1292861. doi: 10.3389/fimmu.2023.1292861. eCollection 2023.
10
CAR-T cells and CAR-Tregs targeting conventional type-1 dendritic cell suppress experimental autoimmune encephalomyelitis.
Front Immunol. 2023 Oct 27;14:1235222. doi: 10.3389/fimmu.2023.1235222. eCollection 2023.

本文引用的文献

1
Cutting edge: De novo induction of functional Foxp3+ regulatory CD4 T cells in response to tissue-restricted self antigen.
J Immunol. 2011 Apr 15;186(8):4551-5. doi: 10.4049/jimmunol.1003573. Epub 2011 Mar 14.
2
Phenotypical and functional specialization of FOXP3+ regulatory T cells.
Nat Rev Immunol. 2011 Feb;11(2):119-30. doi: 10.1038/nri2916.
3
An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4(+) T cells.
Genes Immun. 2011 Mar;12(2):116-25. doi: 10.1038/gene.2010.54. Epub 2010 Dec 23.
4
Human regulatory T cells in autoimmune diseases.
Curr Opin Immunol. 2010 Dec;22(6):753-60. doi: 10.1016/j.coi.2010.08.012. Epub 2010 Sep 24.
5
Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes.
J Immunol. 2010 Oct 1;185(7):3814-8. doi: 10.4049/jimmunol.1001860. Epub 2010 Sep 1.
7
Differential but direct abolishment of human regulatory T cell suppressive capacity by various TLR2 ligands.
J Immunol. 2010 May 1;184(9):4733-40. doi: 10.4049/jimmunol.0804279. Epub 2010 Apr 2.
8
Unraveling the genetics of autoimmunity.
Cell. 2010 Mar 19;140(6):791-7. doi: 10.1016/j.cell.2010.03.003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验